CeQur

CeQur is a medical technology company, which has developed an insulin infuser for the care of type 2 Diabetes mellitus patients.

The CeQur device is a small discreet and wearable insulin patch infuser. It will be one of the smallest and easiest continuous delivery options as it will administer the basal and bolus rates of insulin over three days. The CeQur insulin infuser includes a disposable insulin reservoir that is connected to a reusable electronic messenger. The device easily attaches to the patient's abdominal area with a safe and secure adhesive backing. The product is currently in clinical trials in Europe. It will compete with delivery pens and syringes on the market, but with the proposed benefit of avoiding daily self-injections, which should increase patients’ compliance and clinical outcome.


Recent News

April 10, 2014
CeQur Appoints Douglas Lawrence Chief Executive Officer

 
March 5, 2014
Diabetes Care Publishes Data Demonstrating PaQ® Insulin Delivery Device Could Help People with Type 2 Diabetes Overcome Barriers to Insulin Adherence and Improve Clinical Outcomes

 
January 8, 2014
CeQur to Present at the 32nd Annual J.P. Morgan Healthcare Conference

 
September 24, 2013
Data Demonstrating Potential Benefits of Simple Insulin Delivery Device Presented at European Association for the Study of Diabetes Annual Meeting

 
September 9, 2013
CeQur SA Closes $27 Million Series B Financing

 
June 22, 2013
New Data Demonstrate Simple Insulin Delivery Device Can Significantly Reduce Barriers to Insulin Treatment Among People with Type 2 Diabetes

 
February 28, 2013
CeQur Announces Positive Results from Study Evaluating Simple Insulin Delivery Device Among People with Type 2 Diabetes

 
November 27, 2012
CeQur Receives CE Mark for PaQ® Insulin Delivery Device

 
September 26, 2012
CeQur Completes Study Evaluating Ability of Simple Insulin Delivery Device to Replace Insulin Injections Among People with Type 2 Diabetes

 
June 16, 2012
Clinical Study begins on Insulin Delivery Device for Type 2s

 
April 13, 2010
CeQur SA names Robert O'Holla EVP for Regulatory Affairs

 
October 7, 2009
CeQur SA Appoints Eric Milledge Chairman of the Board of Directors

 
January 5, 2009
CeQur SA Completes Series A Investment with 10 Million Dollar Raise in December 2009

 


Company Info
 
Country: Switzerland
Industry:    LS
Sector: medical technology
Status: Unrealized
Vehicle: Endeavour II LP


Key persons
 Eric Milledge, Chairman; James Peterson, CEO


Company website
 www.cequrcorp.com


Endeavour Vision Team
 
Damien Tappy
Daniel Bertholet
© Endeavour Vision SA 2006-2014 Terms & Conditions